Dr. Kenneth Cusi, MD
Claim this profileUniversity of Florida
Studies Nonalcoholic Steatohepatitis
Studies Non-alcoholic Fatty Liver Disease
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Kenneth Cusi, MD is currently running
Low-Dose Pioglitazone
for NASH
This trial is testing a small daily dose of pioglitazone in patients with type 2 diabetes and a specific liver condition called NASH. The goal is to see if this medication can improve their liver health by helping their bodies manage blood sugar and fat levels better.
Recruiting1 award Phase 25 criteria
Observational Study
for Fatty Liver Disease
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.
Recruiting1 award N/A1 criteria
More about Kenneth Cusi, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kenneth Cusi, MD has experience with
- Pioglitazone
- Placebo
Breakdown of trials Kenneth Cusi, MD has run
Nonalcoholic Steatohepatitis
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Fatty Liver Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth Cusi, MD specialize in?
Kenneth Cusi, MD focuses on Nonalcoholic Steatohepatitis and Non-alcoholic Fatty Liver Disease. In particular, much of their work with Nonalcoholic Steatohepatitis has involved treating patients, or patients who are undergoing treatment.
Is Kenneth Cusi, MD currently recruiting for clinical trials?
Yes, Kenneth Cusi, MD is currently recruiting for 2 clinical trials in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that Kenneth Cusi, MD has studied deeply?
Yes, Kenneth Cusi, MD has studied treatments such as Pioglitazone, Placebo.
What is the best way to schedule an appointment with Kenneth Cusi, MD?
Apply for one of the trials that Kenneth Cusi, MD is conducting.
What is the office address of Kenneth Cusi, MD?
The office of Kenneth Cusi, MD is located at: University of Florida, Gainesville, Florida 32610 United States. This is the address for their practice at the University of Florida.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.